February 28, 2018 — Guerbet will present its new Contrast&Care application, as well as other contrast media offerings for computed tomography (CT), the cath lab and magnetic resonance imaging (MRI), at the the 2018 European Congress of Radiology (ECR), Feb. 28-March 4 in Vienna, Austria.
Contrast&Care is a class I /CE medical device designed to be used by healthcare professionals only. It is a contrast media injection management solution that enables imaging centers to collect, archive, examine and share injection data, including data on contrast products, adverse events, injector activity, information on estimated glomerular filtration rate (eGFR) and other risk factors before an exam. The solution enables all the information on injections during medical imaging examinations (contrast media, protocols, patient data, etc.) to be combined, and interfaces with the information systems used in radiology such as the radiology information system (RIS) and picture archiving and communication system (PACS) .
With this new solution, available in seven languages, Guerbet said it now features product offerings across the entire value chain. Contrast&Care complements Guerbet's digital services offering in synergy with Dose&Care, the operational solution for tracking patient exposure to ionizing rays. Contrast&Care and Dose&Care will be demonstrated at Guerbet's booth throughout the event.
For more information: www.guerbet.com
April 18, 2024 
